Archemix IPO aims to raise $64 million

10/24/2007 | MSN Money

Cambridge, Mass.-based Archemix Corp. says it plans to issue 4.5 million shares of stock in its IPO, which is intended to raise about $64 million. The funds will be used for R&D for new preclinical and clinical drug candidates including aptamer products for cardiovascular disease, blood disorders and cancer.

View Full Article in:

MSN Money

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT